Variation name (cDNA level) | Variation name (protein level) | Variation status | Variation class |
c.IVS33+2T>C (c.4210+2T>C) | Heterozygous | Mutation |
wt codon | wt aa | mutant codon | mutant aa | mutational event | mutation type |
GAC | Asp | spl+2 | Spl. | T->C | Ts |
Structure | Key Residue (HCD) | Pyrimidin doublet | CpG |
cb EGF-like #20 | Ca2+ binding |
At the mRNA level | On restriction map |
Not tested on cDNA | New restriction site(s): none Lost restriction site(s): none |
Impact on splicing | ||||||||||
Splice site type | Wild type sequence | CV | Mutant type sequence | CV | Variation (%) | |||||
CAGgtatgt |
| CAGgcatgt |
| -29.4 % |
Sample ID | Patient status | Gender | Transmission | Age of onset | Age of death | Geographic origin |
USA04NOR F0015 I3477 | Proband | Male | NA | Unknown | U.S.A |
Phenotypic group | Disease |
NA | Classical MFS |
Symptom |
C-Asc. aortic dilatation |
C-Mitral valve prolapse |
C-Tricuspid valve prolapse |
O-Ectopia lentis |
S-Chest deformity (unspecified) |
S-Increased body length |
S-Joint hypermobility (m) |
S-Plain pes planus (M)(1) |
Reference ID | PubMed ID | Reference |
102 | - | Hyland JC (Personal communication 2003). |